3+DTaP‡
4+DTaP§
3+Polioll
1+MMR¶
3+Hib**
3+Hib-S††
Hib by brand‡‡
3+HepB§§
HepB Birth dosellll
1+Var¶¶
3+PCV***
4+PCV†††
2+HepA‡‡‡
Rotavirus§§§
4:3:1llllll
4:3:1:3:3:1¶¶¶
4:3:1:3:3:1-S****
4:3:1:4:3:1€
4:3:1:3:3:1:4?
4:3:1:3:3:1:4-S€€
4:3:1:4:3:1:4??
4:3:1:0:3:1:4€€€
4:3:1:0:3:1:4-2008???
| * Estimate=NA (Not Available) if the unweighted sample size for the denominator was <30 or (CI half width)/Estimate > 0.6, otherwise estimates | ||||||||||||
| are presented as point estimates (%) + 95% confidence intervals. NA for 2008 indicate areas that were not sampled in 2008 or not comparable to 2009. | ||||||||||||
| † Children in the Q1/2009-Q4/2009 National Immunization Survey were born between January 2006 and July 2008. | ||||||||||||
| ¥ US National estimates include the 50 States plus DC, and exclude the Virgin Islands. | ||||||||||||
| ‡ 3 or more doses of any diphtheria and tetanus toxoids and pertussis vaccines including diphtheria and tetanus toxoids, and acellular pertussis vaccine (DTaP). | ||||||||||||
| § 4 or more doses of DTaP. | ||||||||||||
| ll 3 or more doses of any poliovirus vaccine. | ||||||||||||
| ¶ 1 or more doses of measles-mumps-rubella vaccine. | ||||||||||||
| ** 3 or more doses of Haemophilus influenzae type b (Hib) vaccine. | ||||||||||||
| †† ≥2 or ≥3 doses of Haemophilus influenzae type b (Hib) vaccinefor the primary series, depending on brand type. | ||||||||||||
| ‡‡ ≥3 or ≥4 doses of Hib vaccine depending on product type received (includes primary series plus the booster dose). | ||||||||||||
| §§ 3 or more doses of hepatitis B vaccine. | ||||||||||||
| llll 1 or more doses of hepatitis B vaccine administered between birth and age 3 days. | ||||||||||||
| ¶¶ 1 or more doses of varicella at or after child's first birthday, unadjusted for history of varicella illness. | ||||||||||||
| *** 3 or more doses of pneumococcal conjugate vaccine (PCV). | ||||||||||||
| ††† 4 or more doses of PCV. | ||||||||||||
| ‡‡‡ 2 or more doses of Hepatitis A vaccine. | ||||||||||||
| §§§ ≥2 or ≥3 or more doses of Rotavirus vaccine, depending on product type received ( ≥2 doses for Rotarix® [RVI] or ≥3 doses for RotaTeq® [RV5]. | ||||||||||||
| llllll 4 or more doses of DTaP, 3 or more doses of poliovirus vaccine, and 1 or more doses of any MMR vaccine. | ||||||||||||
| ¶¶¶ 4:3:1 plus 3 or more doses of Hib vaccine of any type, 3 or more doses of HepB vaccine, and 1 or more doses of varicella vaccine. | ||||||||||||
| **** 4:3:1 plus ≥2 or ≥3 doses of Hib vaccine depending on brand type (primary series only), 3 or more doses of HepB, and 1 or more doses of varicella vaccine. | ||||||||||||
| € 4:3:1 plus ≥3 or ≥4 doses of Hib vaccine, depending on brand type (primary plus booster dose), 3 or more doses of HepB vaccine, 1 or more doses of varicella vaccine. | ||||||||||||
| ? 4:3:1 plus ≥3 doses of Hib vaccine of any type, 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV. | ||||||||||||
| €€ 4:3:1 plus ≥2 or ≥3 doses of Hib vaccine depending on brand type (primary series only), 3+ doses of HepB vaccine, 1+ doses of varicella vaccine, and 4+ doses of PCV. | ||||||||||||
| ?? 4:3:1 plus ≥3 or ≥4 doses of Hib vaccine depending on brand type (primary plus booster dose), 3 or more doses of HepB, 1 or more doses of varicella vaccine, and 4 or more doses of PCV. | ||||||||||||
| €€€ 4:3:1 plus 3 or more doses of HepB vaccine, 1 or more doses of varicella vaccine, and 4 or more doses of PCV. Hib vaccine is excluded. | ||||||||||||
| ??? 2008 estimates for 4:3:1 plus 3 or more doses of HepB vaccine, 1 or more doses of varicella vaccine, and 4 or more doses of PCV. Hib vaccine is excluded. | ||||||||||||
| tab03_antigen_state | ||||||||||